-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624.O1.6 624. Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Advances in Treating T Cell Lymphomas

Symposia: Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Hodgkin lymphoma, Lymphomas, Clinical Research, T Cell lymphoma, Diseases, Lymphoid Malignancies
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Grand Hall B (Manchester Grand Hyatt San Diego)
Moderators:
Enrica Marchi, MD, PhD, University of Virginia and Reid W. Merryman, MD, Dana-Farber Cancer Institute, Harvard Medical School
Disclosures:
No relevant conflicts of interest to declare.
The proposed session will present abstracts on the topic of clinical trial and observation studies in classical Hodgkin lymphoma and NK/T cell lymphomas
4:00 PM

Seok Jin Kim, MD, PhD1, Sang Eun Yoon, MD., PhD2*, Deok-Hwan Yang, MD, PhD3*, Sung Yong Oh, MD4*, Yoon Seok Choi, MD, PhD5, Seong Hyun Jeong, MD6*, Min Kyoung Kim, MD., PhD7*, Sung-Nam Lim, MD8*, Junhun Cho, MD., PhD9* and Won Seog Kim, MD, PhD10*

1Samsung Med. Ctr., Seoul, Korea, Republic of (South)
2Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
3Hematology-Oncology, Chonnam National University Hwasun Hospital, Hawsun, Jeollanam-Do, Korea, Republic of (South)
4Dept. of Hem.-Onc., Internal Med., Pusan, KOR
5Ajou University School of Medicine, Suwon, Korea, Republic of (South)
6Department of Internal Medicine, Ajou University School of Medicine, Suwon, KOR
7Yeungnam University College of Medicine, Daegu, Korea, Republic of (South)
8Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South)
9Samsung Medical Center, SEOUL, KOR
10Samsung Medical Center, Seoul, KOR

4:15 PM

Steven M. Horwitz, MD1, Koji Izutsu, MD, PhD2, Neha Mehta-Shah, MD3, Raul Cordoba, MD, PhD4, Stefan K. Barta, MD, MRCP, MS5*, Emmanuel Bachy, MD, PhD6*, Giuseppe Gritti7*, Eric Jacobsen, MD8, Shigeru Kusumoto, MD, PhD9, Yann Guillermin, MD10*, Anca Prica, MD11, Dok Hyun Yoon, MD, PhD12*, Eva Domingo Domenech, MD13*, Jie Wang, MD, MS14, Jin Seok Kim, MD, PhD15*, Kate Cwynarski, MBBS, PhD, FRCP, FRCPath16*, Marjolein van der Poel, MD, PhD17*, Ai Inoue, MD, PhD18*, Jin Jin, PhD18*, Sutan Wu, PhD18*, Keiko Nakajima, MD, MSc18* and Pier Luigi Zinzani, MD, PhD19

1Memorial Sloan Kettering Cancer Center, New York, NY
2National Cancer Center Hospital, Tokyo, Japan
3Division of Oncology, Washington University School of Medicine, Saint Louis, MO
4Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
5Perelman Center for Advanced Medicine - University of Pennsylvania, Philadelphia, PA
6Lyon-Sud Hospital Center, Pierre-Bénite, France
7ASST Papa Giovanni XXIII, Bergamo, Italy
8Dana-Farber Cancer Institute, Boston, MA
9Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
10Léon Bérard Center, Lyon, France
11University Health Network, Toronto, ON, Canada
12Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
13Institut Catalá d'Oncologia L'Hospitalet, Barcelona, Spain
14Duke Cancer Center, Durham, NC
15Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of (South)
16University College London Hospital, London, United Kingdom
17Maastricht University Medical Center, Maastricht, Netherlands
18Daiichi Sankyo Inc., Basking Ridge, NJ
19IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli” and Dipartimento di Scienze Mediche e Chirurgiche,  Università di Bologna, Bologna, Italy

4:30 PM

Eric Jacobsen, MD1, Dai Maruyama, MD, PhD2, Pierluigi Porcu, MD3, Kensei Tobinai, MD, PhD2, Pamela B. Allen, MD4, Kenji Ishitsuka, MD, PhD5*, Kunihiro Tsukasaki, MD, PhD6, Shigeru Kusumoto, MD, PhD7, Francine M. Foss, MD8, Nobuhiko Yamauchi, MD9*, Satoko Morishima, MD, PhD10*, Yoshitaka Imaizumi, MD, PhD11,12*, Koji Izutsu, MD, PhD2, Tatyana Feldman, MD13, Toyotaka Kawamata, MD, PhD14,15*, Yasuyuki Kakurai, PhD16*, Hideyuki Yamauchi, MSc16*, Noha Biserna, MSc17*, Ai Inoue, MD, PhD17*, Shinji Tsutsumi, PhD17* and Steven M. Horwitz, MD18

1Dana-Farber Cancer Institute, Boston, MA
2National Cancer Center Hospital, Tokyo, Japan
3Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
4Emory University, Atlanta, GA
5Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan
6Department of Hematology, Saitama Medical University International Medical Center, Saitama, Japan
7Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
8Yale University School of Medicine, New Haven, CT
9National Cancer Center Hospital East, Chiba, Japan
10University of the Ryukyus Hospital, Okinawa, Japan
11Department of Hematology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan
12Nagasaki University Hospital, Nagasaki, Japan
13John Theurer Cancer Center at Hackensack Meridian Health School of Medicine, Hackensack, NJ
14Department of Hematology/Oncology, The Institute of Medical Science, University of Tokyo, Tokyo, Japan
15Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan
16Daiichi Sankyo Co., Ltd., Tokyo, Japan
17Daiichi Sankyo Inc., Basking Ridge, NJ
18Memorial Sloan Kettering Cancer Center, New York, NY

4:45 PM

Huangming Hong1*, Mingzhi Zhang2*, Zhigang Peng, MD3*, Jianzhen Shen, MD4*, Yuerong Shuang5*, Hui Zhou6, Hongqiang Guo, MD7*, He Huang8*, Fei Li9*, Zhengzi Qian10*, Lihong Liu11*, Liang Wang, M.D, PhD12*, Wei Yang, MD13*, Liling Zhang14*, Pengcheng He15*, Shen Qian, MD16*, Fugen Li16*, Meng Li16* and Tongyu Lin, MD17*

1Sichun Cancer Hospital, Chengdu, AL, China
2The First Affiliated Hospital of Zhengzhou University and Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China
3The First Affiliated Hospital of Guangxi Medical University, Nanjing, China
4Fujian Medical University Union Hospital, Fuzhou, China
5Jiangxi Cancer Hospital, Nanchang, China
6Hunan Cancer Hospital, Changsha, China
7Henan Cancer Hospital, Zhengzhou, China
8Sun Yat-Sen University Cancer Center, Guangzhou, China
9The First Affiliated Hospital of Nanchang University, Nanchang, China
10Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
11The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
12Beijing Tongren Hospital, Capital Medical University, Beijing, China
13Shengjing Hospital of China Medical University, Shenyang, China
14Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
15The First Affiliated Hospital of Xi'an Jiaotong University, Xian, China
16Haihe Biopharma Co., Ltd., Shanghai, China
17Sichuan Cancer Hospital, Chengdu, China

5:00 PM

Yuqin Song, MD1, Luis Malpica, MD2*, Qingqing Cai, PhD3*, Weili Zhao4, Keshu Zhou, MD5*, Jianqiu Wu6*, Huilai Zhang, MD7*, Kaiyang Ding8*, Yao Liu, PhD, MD9, Zengjun Li10*, Neha Mehta-Shah, MD11, Liling Zhang12*, Meifang Zheng13*, Jie Jin14, Haiyan Yang15, Yuerong Shuang16*, Dok Hyun Yoon, MD, PhD17*, Sujun Gao18*, Wenyu Li19*, Zhimin Zhai, MD20, Liqun Zou, MD, PhD21*, Yaming Xi22*, Youngil Koh, MD23, Fei Li24*, Miles Prince, MBBS (Hons), MD, FRACP, FRCPA, AFRCMA, MACD, FAHMS25, Hui Zhou26, Lie Lin, MD27*, Hui Liu28*, Zhenfan Yang, PhD29, Won Seog Kim, MD, MPH, PhD30* and Jun Zhu, PhD31

1Peking University Cancer Hospital and Institute, Beijing, China
2Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
4Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
5Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
6Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
7Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
8Anhui Provincial Cancer Hospital, Hefei, China
9Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China
10Department of Lymphoma and Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, Shandong, China
11Division of Oncology, Washington University School of Medicine, Saint Louis, MO
12Wuhan Tongji Union Hospital, Wuhan, China
13Linyi Cancer Hospital, Linyi, China
14The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
15Department of Lymphatic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
16Jiangxi Cancer Hospital, Nanchang, China
17Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
18The First Hospital of Jilin University, Changchun, China
19Guangdong Provincial People's Hospital, Guangzhou, China
20The Second Affiliated Hospital of Anhui Medical University, Hefei, China
21West China Hospital of Sichuan University, Chengdu, China
22The First Hospital of Lanzhou University, Lanzhou, CHN
23Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
24The First Affiliated Hospital of Nanchang University, Nanchang, China
25Epworth Hospital, Melbourne, Australia
26Hunan Cancer Hospital, Changsha, China
27Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China
28Beijing Hospital, Beijing, China
29Dizal Pharmaceutical, China, Shanghai, China
30Samsung Medical Center, Seoul, Korea, Republic of (South)
31Peking University Cancer Hospital, Beijing, China

5:15 PM

Yuqin Song, MD1, Zengjun Li2*, Huijing Wu, MD3*, Jie Jin, MD4, Hui Zhou5, Keshu Zhou, MD6*, Liling Zhang7*, Zhigang Peng, MD8*, Zhiye Zhang, MD9*, Hong Cen, MD10*, Youchao Jia, MD11*, Yuerong Shuang12*, Zhiming Li13*, Haiyan Yang14*, Liqun Zou, MD, PhD15*, Zhifeng Li16*, Zhihui Zhang, MD17*, Junmin Li18*, Junning Cao19, Lugui Qiu20, Shaojie Wu21*, Tiejun Gong22*, Xiaohong Xu, MD23*, Zhen Wang, MD24* and Jun Zhu, PhD25

1Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
2Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3Hubei Cancer Hospital, Wuhan, China
4Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Hunan Cancer Hospital, Changsha, China
6Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
7Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, NANING, CHN
9Department of Oncology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
10Department of Medical Oncology, Guangxi Medical University Affiliated Tumor Hospital, Nanning, CHN
11Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, China
12Jiangxi Cancer Hospital, Nanchang, China
13Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
14Zhejiang Cancer Hospital, Hangzhou, China
15Department of Medical Oncology, West China School of Medicine, West China Hospital of Sichuan University, Chengdu, China
16Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Xiamen, China
17Sichuan Cancer Hospital and Institute, Chengdu, China
18Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
19Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
20State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
21Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
22Institute of Hematology and Oncology, Harbin First Hospital, Harbin, CHN
23Department of Hematology and Lymphoma, Cancer Hospital affiliated to Nantong University, Nantong, China
24Linyi Cancer Hospital, Linyi, China
25Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

*signifies non-member of ASH